SECsense Logo

Supernus Pharmaceuticals 8-K Filing: Key Event Update on February 11, 2025

$SUPN
Form 8-K
Filed on: 2025-02-11
Source
Supernus Pharmaceuticals 8-K Filing: Key Event Update on February 11, 2025

From the provided XML section of a financial report, the following key information can be extracted:

  1. Filing Information:
  • Filing Type: 8-K (a report of unscheduled material events or corporate changes)
  • Filing Date: February 11, 2025
  1. Company Information:
  • Company Name: Supernus Pharmaceuticals, Inc.
  • State of Incorporation: Delaware (DE)
  • CIK (Central Index Key): 0001356576
  • SEC File Number: 001-35518
  • Employer Identification Number (EIN): 20-2590184
  • Address: 9715 Key West Ave, Rockville, MD 20850
  • Phone Number: 301-838-2500
  1. Securities Information:
  • Security Type: Common Stock
  • Par Value: $0.001 per share
  • Ticker Symbol: SUPN
  • Exchange: NASDAQ
  1. Context Information:
  • Report Period: The report is for a single date, February 11, 2025.

Insights:

  • The submission of an 8-K filing indicates that Supernus Pharmaceuticals may have experienced a significant event that necessitates timely disclosure to investors.
  • The report is related to a specific date rather than a range, which suggests it may pertain to a specific event or decision made on that day rather than a financial performance update.
  • The company operates in the pharmaceutical sector, which may imply regulatory scrutiny and potential impacts on stock performance based on drug approvals or clinical trial outcomes.

This information is crucial for stakeholders and analysts monitoring the company's developments, regulatory compliance, and potential market reactions.